AXGN Stock Analysis: Buy, Sell, or Hold?
AXGN - Axogen, Inc. Common Stock
$40.58
-3.04 (-6.97%)
▼
5d:
-11.57%
30d:
-5.34%
90d:
+22.9%
WAIT
LOW Confidence
Analysis Updated: Jul 10, 2026 12:00 AM ET
Earnings: Aug 04, 2026
21d
Get Alerted When AXGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called AXGN this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: AXGN is down 11.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: AXGN is down 11.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$35.46
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$22.02
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AXGN is currently trading at $40.58, which is considered oversold relative to its 30-day fair value range of $41.38 to $45.16. The stock's valuation (Forward PE: 55.7) is in line with its historical norms (56.3). Remarkably, the market is currently pricing in an annual earnings decline of 0.4% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, AXGN is in a strong uptrend. The price is currently testing key support at $39.55. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $50.78 (+25.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AXGN is in a strong uptrend. The price is currently testing key support at $39.55. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $50.78 (+25.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$41.38 -
$45.16
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.8%
Protect Your Profits
Holding AXGN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-7.0%)
- BULLISH: Trading 25.1% below Wall St target ($50.78)
- WARNING: Recommendation downgraded due to -11.6% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$41.38 -
$45.16
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$39.55
Resistance Level
$46.95
Current Trend
Strong Uptrend
Technical data as of
Jul 10, 2026
Fundamental Context
Forward P/E (Next Year Est.)
55.72
Wall Street Target
$50.78
(+25.1%)
Revenue Growth (YoY)
26.6%
Profit Margin
-13.2%
Valuation Discount vs History
-0.4% cheaper
PE vs Historical
55.7 vs 56.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.4%
(market-implied from PE analysis)
1-Year Target
$40.42
(0%)
2-Year Target
$40.26
(-1%)
3-Year Target
$40.09
(-1%)
3-Yr Target (if PE normalizes)
(PE: 56→56)
$40.51
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 55.7, Growth: 49.1%)
$134.39
(+231%)
Base:
(SPY PE: 21.8, Growth: 49.1%)
$52.53
(+30%)
Bear:
(PE: 18.5, Growth: 49.1%)
$44.65
(+10%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 55.7 to 56.3
Stabilization Target:
$41.00
(+1.0%)
PE Expansion Potential:
+1.0%
Share & Embed Analysis
Last updated: July 13, 2026 7:08 AM ET
Data refreshes hourly during market hours. Next update: 8:08 AM
Data refreshes hourly during market hours. Next update: 8:08 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AXGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Erick Wayne Devinney
SELL
5221 shares
2026-03-16
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$74 | 65 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 58 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$116 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$97 | 66 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$239 | 58 HOLD |
Advanced AXGN Option Strategies
Professional options setups generated by AI based on today's AXGN price and gamma walls.
